GEN Exclusives

More »

GEN News Highlights

More »
Dec 13, 2011

Quintiles Deepens China Commitment with New CRO

  • Quintiles is reporting the launch of Kun Tuo, a contract research organization (CRO) based in China. It has been established to service the needs of the Chinese biopharmaceutical industry and multinational biopharma companies operating in China.

    Quintiles has had much CRO success at the global level. It has reportedly been conducting clinical trials in China since 1997. Kun Tuo will tap into this expertise and resources, with a focus on developing customized solutions to help local and global biopharma companies achieve successful registration of new medicines in China.

    Kun Tuo will provide a full range of services including clinical trial management, regulatory submission preparation, biostatistics, and data management. It will develop customized offerings in key therapeutic areas along with vaccines, late-phase studies, medical devices, and diagnostics.

    “Kun Tuo will leverage Quintiles’ quality and training systems to offer customized, high-quality solutions best suited for local Chinese biopharma as well as global biopharma local affiliates,” said Ling Zhen, GM, Quintiles China. “We have an aggressive growth plan for China and anticipate doubling Quintiles total staff during 2012 as we look to provide our customers with the solutions they need to succeed in one of the world’s most dynamic marketplaces.” Quintiles China today has more than 300 staff to cover all population centers and study sites in China.


Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Megamerger Dealzapoppin Poll

What company not in this week’s M&A headlines do you think will be at the center of a megamerger, acquisition, or partial selloff this year?